Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

Clinical trial NCT06356194 · COMPLETED

Trial details

NCT number: NCT06356194
Sponsor: Atea Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study

Start date: 2024-04-15
Primary completion: 2024-05-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.